Search
for
Sort by
Research 601–630 of 1000+
- Genetic Defects of Female Sexual Differentiation
- Dermatologic care of the transgender patient - eScholarship
- Unravelling the link between insulin resistance and androgen excess
- Metabolic Aspects of Polycystic Ovary Syndrome
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Novel drugs of United States Food and Drug Administration approved in 2024
- Serum Ferritin Levels: A Clinical Guide in Patients With Hair Loss
- HAIR REGROWTH
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Obesity and polycystic ovary syndrome
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Nutrition and hair
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Telogen effluvium
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Alopecia Areata
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Several biological benefits of the low color temperature light-emitting diodes based normal indoor lighting source
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Morphological Approach to Hair Disorders
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Interventions for female pattern hair loss
- Androgens in women
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Clinical Approach to the Patient With Alopecia